NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Health Information Services · USD

OptimizeRx Corporation (OPRX) Stock Analysis

OptimizeRx Corporation (OPRX) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

OPRX

$7.87

−$0.08 (−1.01%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OPRX with… →

OPRX Key Statistics

As of Sep 4, 2026
Trading
Open
$7.84
Previous Close
$7.95
Day's Range
7.66–7.90
52-Week Range
4.54–22.25
Volume
82.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.09
Valuation
Market Cap
$148.24M
P/E Ratio
31.48
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
7.44
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.61
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.50
EPS (ttm)Profit attributable to each share over the last twelve months.
0.25
Financials (FY)
Revenue (FY)
$109.43M+18.78%
Net Income (FY)
$5.13M
Profit marginThe share of revenue left as profit after all costs and taxes.
4.66%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
18.84M
1-Year Return
−57.71%
Dividend and dates
Earnings Date
November 5, 2026
Avg Volume
314.63K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

OPRX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−35.81%
2025+152.26%
2024−66.04%
2023−14.82%
2022−72.95%
2021+99.33%
2020+203.41%
2019−6.38%
2018+132.91%
2017+93.83%
2016 (partial year)−28.95%

As of September 4, 2026.

OPRX Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$109.43M$5.13M4.7%
2024$92.13M−$20.11M−21.8%
2023$71.52M−$17.57M−24.6%
2022$62.45M−$11.44M−18.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$109.43M$73.60M$12.06M$5.13M4.7%
2024$92.13M$59.38M−$6.22M−$20.11M−21.8%
2023$71.52M$42.90M−$17.52M−$17.57M−24.6%
2022$62.45M$38.97M−$12.29M−$11.44M−18.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OPRX Valuation vs Health Information Services Median

Median of 53 stocks
MetricOPRXHealth Information Services medianvs median
P/E31.4841.1323% below
P/S ratio1.502.6643% below
Profit margin4.66%0.00%4.7 pts above

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values OptimizeRx Corporation (OPRX) at $148.24M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 132 employees.

The 52-week range on file runs from $4.54 to $22.25. OPRX last closed at $7.87 on September 4, 2026. That is −$0.08 (−1.01%) against the previous close. The latest close sits 73.35% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $109.43M. That is +18.78% against the prior fiscal year, when revenue was $92.13M. Net income for the same year was $5.13M. The reported profit margin is 4.66%. That is 4.7 percentage points above the Health Information Services median of 0%. Trailing earnings per share are 0.25.

Across the 4 fiscal years on file, revenue moves from $62.45M in 2022 to $109.43M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

OPRX trades at a trailing price-to-earnings ratio of 31.48. That is 23.46% below the Health Information Services median of 41.13. The forward P/E on file is 7.44. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.61. The price-to-sales ratio is 1.5. On price-to-sales that is 43.49% below the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

Over the trailing twelve months the price has returned −57.71%. Measured over 10 years, that is +9.08% a year compounded. Beta against the wider market is reported at 1.09. Annualized volatility over the trailing 10 years is 72.49%.

Growth & Income

The record shows no dividend for OPRX.

So far in 2026 the price is −35.81%. Across the complete calendar years on file, 2020 returned +203.41% and 2022 returned −72.95%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

OptimizeRx Corporation (OPRX) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
OptimizeRx Corporation OPRX $148.24M 31.5
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. OptimizeRx Corporation trades at a P/E of 31.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About OptimizeRx Corporation

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Visit website →